Kriya Therapeutics
Morrisville, North Carolina, United States · Biotechnology, research · 199 employees
Kriya is a biopharmaceutical company on a mission to revolutionize medicine by developing gene therapies that aim to eliminate human suffering and free people from the burden of chronic disease. With operations in Research Triangle Park, North Carolina, and Palo Alto, California, Kriya has raised over $600 million to advance a broad pipeline of gene therapies in ophthalmology, metabolic disease, a
Funding history
- Funding Round — $320.8M — Sep 2025
- Funding Round — $313.3M — Aug 2025
- Funding Round — $361.8M — Jul 2023
- Funding Round — $270.5M — May 2022
- Funding Round — $320.8M — Jul 2021
Recent signals
- Sep 10, 2025: Raised $320.8M
- Aug 15, 2025: Raised $313.3M
- Jul 27, 2023: Raised $361.8M
- May 24, 2022: Raised $270.5M
- Jul 14, 2021: Raised $320.8M
- Aug 18, 2020: Raised $87.6M
See plans & pricing → Track Kriya Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.